PURPOSE: To create a preoperative prediction model for estimating the risk of non-organ-confined (pT3-4 or pN+) bladder urothelial cancer (NOC-BUC) in patients with clinically OC-BUC (cT1-2N0M0). METHODS: The study involved 248 consecutive patients who had undergone radical surgery for clinically OC-BUC at a tertiary cancer center between 2003 and 2011. Logistic regression analysis was used to develop a prediction model for estimating the risk of pathological NOC disease. Prespecified predictors included age, gender, recurrent frequency, tumor size and number, hydronephrosis, and pathological characteristics at transurethral resection (T-stage, tumor grade, lymphovascular invasion (LVI), and carcinoma in situ). Discrimination ability was measured by the area under the receiver operating characteristic curve (AUC). RESULTS: Overall, 39.1 % of the patients with clinically OC-BUC had NOC disease at the time of radical surgery. In multivariate analysis, recurrent frequency, tumor size, hydronephrosis, and three pathological features at transurethral resection (T-stage, tumor grade, and LVI) were significantly associated with disease extent. The final prediction model included seven variables after backward elimination and achieved a bootstrap-corrected AUC of 0.79. Internal validation showed good calibration and clinical usefulness of the nomogram. CONCLUSIONS: Based on readily available clinicopathological parameters, we developed a nomogram for predicting NOC tumor in clinically OC-BUC. Despite reasonable performance in internal validation, the prediction model should be assessed in external dataset before applied in clinical setting.
PURPOSE: To create a preoperative prediction model for estimating the risk of non-organ-confined (pT3-4 or pN+) bladder urothelial cancer (NOC-BUC) in patients with clinically OC-BUC (cT1-2N0M0). METHODS: The study involved 248 consecutive patients who had undergone radical surgery for clinically OC-BUC at a tertiary cancer center between 2003 and 2011. Logistic regression analysis was used to develop a prediction model for estimating the risk of pathological NOC disease. Prespecified predictors included age, gender, recurrent frequency, tumor size and number, hydronephrosis, and pathological characteristics at transurethral resection (T-stage, tumor grade, lymphovascular invasion (LVI), and carcinoma in situ). Discrimination ability was measured by the area under the receiver operating characteristic curve (AUC). RESULTS: Overall, 39.1 % of the patients with clinically OC-BUC had NOC disease at the time of radical surgery. In multivariate analysis, recurrent frequency, tumor size, hydronephrosis, and three pathological features at transurethral resection (T-stage, tumor grade, and LVI) were significantly associated with disease extent. The final prediction model included seven variables after backward elimination and achieved a bootstrap-corrected AUC of 0.79. Internal validation showed good calibration and clinical usefulness of the nomogram. CONCLUSIONS: Based on readily available clinicopathological parameters, we developed a nomogram for predicting NOCtumor in clinically OC-BUC. Despite reasonable performance in internal validation, the prediction model should be assessed in external dataset before applied in clinical setting.
Authors: Pierre I Karakiewicz; Shahrokh F Shariat; Ganesh S Palapattu; Paul Perrotte; Yair Lotan; Craig G Rogers; Gilad E Amiel; Amnon Vazina; Amit Gupta; Patrick J Bastian; Arthur I Sagalowsky; Mark Schoenberg; Seth P Lerner Journal: Eur Urol Date: 2006-06-23 Impact factor: 20.096
Authors: Daniel Canter; Christopher Long; Alexander Kutikov; Elizabeth Plimack; Ismail Saad; Megan Oblaczynski; Fang Zhu; Rosalia Viterbo; David Y T Chen; Robert G Uzzo; Richard E Greenberg; Stephen A Boorjian Journal: BJU Int Date: 2011-01 Impact factor: 5.588
Authors: Matthew J Resnick; Meredith Bergey; Laurie Magerfleisch; John E Tomaszewski; S Bruce Malkowicz; Thomas J Guzzo Journal: BJU Int Date: 2010-09-29 Impact factor: 5.588
Authors: Richard J Sylvester; Adrian P M van der Meijden; Willem Oosterlinck; J Alfred Witjes; Christian Bouffioux; Louis Denis; Donald W W Newling; Karlheinz Kurth Journal: Eur Urol Date: 2006-01-17 Impact factor: 20.096
Authors: Robert S Svatek; Shahrokh F Shariat; Giacomo Novara; Eila C Skinner; Yves Fradet; Patrick J Bastian; Ashish M Kamat; Wassim Kassouf; Pierre I Karakiewicz; Hans-Martin Fritsche; Jonathan I Izawa; Derya Tilki; Vincenzo Ficarra; Bjoern G Volkmer; Hendrik Isbarn; Colin P Dinney Journal: BJU Int Date: 2011-01-18 Impact factor: 5.588
Authors: Ewout W Steyerberg; Andrew J Vickers; Nancy R Cook; Thomas Gerds; Mithat Gonen; Nancy Obuchowski; Michael J Pencina; Michael W Kattan Journal: Epidemiology Date: 2010-01 Impact factor: 4.822
Authors: Claus Rödel; Gerhard G Grabenbauer; Reinhard Kühn; Thomas Papadopoulos; Jürgen Dunst; Martin Meyer; Karl M Schrott; Rolf Sauer Journal: J Clin Oncol Date: 2002-07-15 Impact factor: 44.544
Authors: M W Kramer; A Heinisch; G Wegener; M Abbas; C von Klot; I Peters; H Tezval; T R Herrmann; M A Kuczyk; A S Merseburger Journal: Urologe A Date: 2014-02 Impact factor: 0.639
Authors: Kamran Zargar-Shoshtari; Homayoun Zargar; Colin P Dinney; Cesar E Ercole; Pranav Sharma; Evan Kovac; Petros D Grivas; Andrew J Stephenson; Jay B Shah; Peter C Black; Philippe E Spiess Journal: World J Urol Date: 2015-08-19 Impact factor: 4.226